Patient and public involvement and engagement in Long COVID research: embedding inclusion in research Authors: L Skipper, M A Faghy, C Thomas, LC PPIE Research Group, R E M Ashton, T Bewick, R Owen Published: 2026 ABSTRACT AbstractBackgroundPatient and public involvement and engagement (PPIE) is increasingly recognised as essential to ensuring that research is safe, inclusive and equitable, yet implementation often remains tokenistic or absent. In the ERASE-LC Trial, patients contribute as collaborators throughout the research process, helping to shape research questions, study design and delivery through their lived experience.DiscussionThis paper provides examples that illustrate how lived experience can be integrated across the research lifecycle, from defining roles and responsibilities to enabling meaningful collaboration. Embedding PPIE within Long COVID research has informed approaches to engagement, accessibility, and participant safety. Although developed in the context of Long COVID, these approaches may be applicable to research in other chronic conditions and wider clinical research settings.ConclusionDrawing on reflections from our PPIE network and a case study from the Long COVID study, the ERASE-LC trial, we illustrate how inclusive and community-representative PPIE can be embedded in practice. These experiences highlight the value of flexible and accessible engagement approaches to inform co-produced recommendations for strengthening PPIE in health research.Clinical trial numberClinicalTrials.gov, NCT05911906, 20/06/2023. What is Patient, Public Involvement and Engagement (PPIE)? Patient and Public Involvement and Engagement (PPIE) is now an established component of health research, reflecting a shift towards more collaborative and inclusive research practice. The National Institute of Health Research defines PPIE as research conducted with, by, or in partnership with patients, carers, and members of the public, rather than to, about, or for them [1]. Its primary purpose is to ensure that research is informed by lived experience, thereby improving relevance, acceptability, ethical conduct, and potential impact. However, despite broad endorsement, PPIE is not always implemented in ways that enable substantive influence. In some contexts, involvement remains limited or tokenistic, particularly when undertaken primarily to meet funder or reporting requirements rather than as an integral part of research design and delivery [2]. When implemented with appropriate structure and resources, PPIE has the potential to strengthen the quality and applicability of research and to enhance the evidence base informing health policy and decision-making, including in emerging and complex conditions such as Long COVID [3–5]. However, challenges, such as practical constraints, including limited time, resources, and support, further restrict meaningful engagement and limit the diversity of contributors. Meaningful PPIE approaches, using the techniques outlined in this case study paper, demonstrate that PPIE is a sustained and supported partnership rather than a discrete activity [6–8]. PPIE guidelines and models The National Institute for Health and Care Research (NIHR) definition of PPIE echoes the patient-led principle of ‘nothing about us without us’ [9]. This definition provides an important conceptual foundation for the research group's current work, which seeks to operationalise these principles within a complex, long-term condition research context. The NIHR positions patients as active, competent partners in shaping meaningful improvements across healthcare systems. Recognised as most effective when embedded across the research lifecycle, PPIE guidelines encourage involvement during the development of research questions, study design and ethical considerations, preparation of participant-facing materials, and interpretation and dissemination of findings [10]. Involvement may take multiple forms, such as advisory groups, steering committees or co-researchers roles, enabling research priorities to better reflect the perspective of those affected [11]. Evidence suggests that meaningful PPIE models can support study feasibility, recruitment and retention, and contribute to the identification of outcomes that matter to patients and the public [3, 12, 13]. The Ethical Practice Guidelines for Public Involvement and Community Engagement (PICE), published in 2024 by the NIHR Applied Research Collaboration (ARC) North East and North Cumbria (NENC), outline ten practical ethical guidelines for public involvement and community engagement [14]. These include safeguarding, access and inclusion, working in sensitive research areas, confidentiality, boundaries, communication, training and support, developing sustainable and reciprocal relationships, managing conflict, and ensuring contributors are explicitly valued [14, 15]. The work within this case study aligned with these guidelines and was designed in recognition that Long COVID is an evolving condition, therefore PPIE could not rely solely on established, stable accounts of lived experience. Instead, PPIE in this context combined contributors’ emerging lived experiences with their prior experience of PPIE processes and research engagement. This approach allowed contributors to shape the research not only through personal experience of an illness with an undulating nature, but also through their understanding of effective involvement, communication, and research governance. Accordingly, the study was explicitly informed by core PPIE principles, particularly reciprocity, clear communication and valuing contributions, which are especially salient in Long COVID research where uncertainty is high and experiential knowledge is continually developing. Despite the advances and increased recognition of PPIE, translating PPIE principles into practice remains challenging. In line with NIHR guidance on reporting PPIE in scientific publications, there is significant variation in the depth and quality of PPIE reporting across journals [16, 17]. While some journals, such as the British Medical Journal [18], Research for All, and BMC Research Involvement and Engagement [16] require detailed and explicit reporting of PPIE, this level of reporting is not applied consistently across the wider publishing landscape. The reporting of PPIE is often constrained by word limits, reducing opportunities for detailed reflection, shared learning and transparency. Isolating involvement to a single subsection risks tokenism rather than integration, therefore practical solutions like the GRIPP2 reporting checklist can be useful in providing consistency across journals and reduce the risk of tokenism [19]. In addition to reporting checklists, supplementary materials offer a pragmatic solution, enabling more comprehensive reporting of PPIE processes, contributions and impacts. In the context of the research group’s current work, this approach provides a mechanism to explicitly value PPIE input and to reflect critically on its influence across study stages. A further limitation in existing PPIE guidance is the lack of consistent and routine evaluation to identify areas for improvement. Researchers, public contributors and policymakers broadly agree that PPIE evaluation is valuable; however, a recent scoping review identified seventy-one PPIE assessment tools implemented in the context of health research between 2021 and 2024 [20]. Nissen et al. describe an inclination within the literature to adapt existing validated tools or create new ones to meet the specific requirements of the local settings eflecting the nuance of PPIE in different health sectors. For example, the tools identified in this review covered mental health, paediatrics, coronavirus disease 2019 (COVID-19), rheumatology and dementia. Existing tools, such as the Quality Service User Involvement Questionnaire, The Council of Medical Specialty Societies (CMSS) and Patient-Led Research Collaborative (PLRC) model, alongside qualitative methods (e.g. focus groups, interviews) offer useful insights but have limitations in isolation. While these frameworks aim to move beyond tokenistic engagement toward meaningful patient-led outcomes, aggregated scores alone provide limited value without contextual interpretation. To date, PPIE within our Long COVID research has not been evaluated using a quantitative instrument. The research was informed by established PPIE guidelines and conceptual frameworks; however, a formal evaluation tool was not applied due to the recognised associated limitations. Consistent with challenges reported in the literature, this represents an opportunity to strengthen evaluation and accountability. The approach used to operationalise, document and evaluate PPIE within this study are outlined below. PPIE reflections on their involvement in health research Despite the well-established positive impact of PPIE within health research, its implementation is not always meaningful. In some cases, PPIE has been adopted in a superficial or symbolic manner, known as ‘tokenism’, where patient and public contributors are included for compliance rather than genuine and authentic collaboration [2, 21]. Tokenistic PPIE often arises from a ‘box-ticking’ mentality, in which involvement is framed as a requirement rather than a genuine effort to co-produce knowledge and improve equity, accessibility, and safety in research [22]. Tokenism could include engagement late in the research process, after key decisions have been made, thereby reducing contributors' influence and impact. Such practices risk reinforcing traditional hierarchies and excluding diverse voices, particularly those from marginalised or underserved communities. Failure to recognise and include these perspectives can limit the relevance, uptake, and ethical robustness of the research [23]. Contributors may feel disempowered or undervalued, which erodes trust and risks deterring future engagement. Importantly, tokenism also represents a missed opportunity to harness the full potential of co-production: a process in which lived experience is not only valued but used to enrich the research process and outcomes. To illustrate how tokenistic PPIE may be experienced in practice, we present anonymised reflections from members of the established PPIE network that contribute to our research activities. These accounts reflect experiences across UK health research, largely studies that are publicly funded, and are not related to the authors' research in Long COVID. They are included to provide lived-experience context to issues described in the literature and to frame the rationale for the use and adoption of alternative approaches to PPIE. While these reflections were not subjected to formal qualitative coding or thematic analysis, the author group collectively reviewed them to identify recurring issues and patterns. Through this process, the authors gained a clearer understanding of how tokenistic practices are perceived by contributors and how these experiences informed the rationale for adopting alternative, more inclusive approaches to PPIE. I have realised my role is minimal and I am only able to support with damage limitation. There have been times when meaningful involvement can be undermined, leaving representatives sidelined, particularly when engagement feels tokenistic or when defensiveness arises on the part of researchers. There are times where we find ourselves excluded because of assumptions made about our views. What can appear to be resistance, in reality, is a different perspective that might not be immediately recognised. These moments reveal how easily complexity can be overlooked when judgments are formed too quickly. I have experienced my name being removed from publications during submission due to a disagreement over wording. I have been involved in projects where there has been dismissal of patient safety concerns with insubstantial rationale provided for said dismissal i.e. fobbing off. This is in addition to a lack of motivation to record adverse outcomes to interventions. I have spent a lot of time working with research groups and have not received any compensation for my involvement. I have attended meetings which at times the pace of conversation felt quite fast, and with the brain fog I experience from Long COVID, it was hard to keep up with the technical detail. A little more time to digest information would have helped me contribute more fully. Because of the fatigue I live with, going through large documents was overwhelming. Shorter summaries or clear key points would have made it much easier to engage. One challenge was that another PPIE representative seemed to use the meetings mainly to air their personal frustrations, rather than looking at the bigger picture as an advocate. This made it harder to focus on constructive discussion, which is especially difficult when living with Long COVID and only having limited energy to contribute. We also present anonymised quotes reflecting on what contributors felt worked well in health research more broadly. These insights were drawn upon to help frame the PPIE approach used in the development and implementation of the research group's work in Long COVID. Time was made to ask and answer questions, which was reassuring. It showed that our input mattered, and it helped me feel confident that nothing I raised was too small or unimportant. As a small team, we were engaged really well throughout the process. There was space for everyone’s voice to be heard, and I never felt overlooked. The close collaboration meant we could build trust quickly, support each other, and contribute ideas that genuinely influenced the work. Being part of the team gave me a sense of purpose during a really difficult time with my Long COVID. My experience has been one of feeling really involved in the research. I have felt heard, taken seriously, and treated with the respect most patients long for when living with the nightmare of Long COVID. I have also made some real friends along the way, which has been an unexpected but very welcome outcome. I felt included from the very beginning, and it was clear my voice helped shape the trial design. The researchers took time to explain things without jargon, which gave me the confidence to speak up. Case study: embedding bespoke and inclusive PPIE in the UK’s first antiviral feasibility trial for long COVID (ERASE-LC) The ERASE-LC trial is the UK’s first open-label clinical feasibility study investigating the potential role of antiviral therapy (Remdesivir) in people living with Long COVID (trial number: NCT05911906). The study aimed to evaluate the feasibility of a 5-day intravenous Remdesivir intervention as a potential treatment option for patients with Long COVID. Participants aged ≥18 years with confirmed or suspected prior SARS-CoV-2 infection and persistent post-COVID symptoms were recruited across NHS and non-NHS sites in Derbyshire and Exeter. Baseline assessments included patient-reported outcome measures (PROMs), clinical history, and cardiopulmonary exercise testing, with Exeter participants also undergoing PET/CT imaging. The treatment phase consisted of five consecutive days of intravenous Remdesivir, with close monitoring for safety and tolerability. Follow-up assessments evaluated quality of life, symptom burden, and functional outcomes. PPIE was embedded from study conception, including the development of the funding application, and was central to both the design and implementation of the study (Fig. 1). From the outset, the research team adopted a co-production approach that prioritised the lived experience of Long COVID, recognising that early and meaningful involvement is essential to strengthening methodological rigour and ensuring the relevance of proposed outcomes. PPIE activities undertaken during the pre-award phase directly informed the refinement of study aims and outcomes to reflect what matters most to patients, shaped inclusion criteria to capture the heterogeneity of symptoms, guided ethical decision-making, and influenced the design of equitable recruitment strategies, particularly for communities disproportionately affected by Long COVID. Central framework guiding the study’s design and implementation within our research Forming the PPIE group for ERASE-LC At project inception, the ERASE-LC group comprised seven PPIE members (three males, four females) aged 35–60 years. Recruitment has been ongoing since 2021, driven by informal conversations with individuals keen to support the research group's work beyond their participation in research, as well as advertisements on patient community platforms and social media. PPIE contributors were motivated by a desire to better understand their condition and ensure safe practices for future participants. Several were no longer working due to ill health but brought diverse employment backgrounds, including medicine, research, rail transport, and diversity and inclusion. These experiences enriched the project, enabling unique contributions at key stages. For example, members with medical and research expertise facilitated clearer communication between clinical and research team members, improving trial design and ensuring that the needs of those living with Long COVID were central. Inclusive and accessible PPIE practices Equity, accessibility, and inclusion are core principles embedded across our research portfolio and team practises. By adopting a truly inclusive approach, we ensure diverse voices are represented at every stage, fostering trust, honesty, transparency, and meaningful co-production. This commitment enhances real-world relevance, participant engagement and methodological rigour, ultimately improving research quality and impact while promoting fairness and shared ownership of outcomes. To achieve this, standard practises were adapted. Meetings were shortened to reduce cognitive and sensory load, and virtual meetings were designed for comfort, encouraging members to recline or lie down to manage orthostatic stress, with no obligation to keep their cameras on. Agendas and materials were provided in advance, often a month in some cases and sometimes by post depending on patient preference, to allow preparation time, and preparatory sessions were held for major updates. Flexible deadlines accommodated periods of ill health, and feedback was welcomed through multiple channels, including voice notes and one-to-one follow-ups for clarification. PPIE representatives were also encouraged to reflect on discussions within meetings in the days or weeks following meetings and provide any reflections, thoughts and feelings about what had been discussed. These adaptations provided greater opportunity for contributors to engage meaningfully, considering variations of symptom severity and energy levels. Ahead of data collection, all research staff completed comprehensive training, which included a patient-focused session delivered by one of the PPIE contributors within the research group. This involved on-site training sessions and training logs that highlighted the role and importance of the patient safety strategy and practical steps to keep participants safe. The training also covered empathetic communication, trauma-informed care, and the impact of medical gaslighting. These sessions fostered a culture of respect and understanding, ensuring that contributors felt psychologically safe and valued. Patient-facing materials were co-created and tested with PPIE partners and diverse patient groups to ensure inclusivity, accessibility, and usability. Materials are designed to accommodate fluctuating energy levels and cognitive processing speeds, with particular attention to health literacy, cultural sensitivity, and the avoidance of medicalised or dismissive language. For example, during the design of the research groups previous Long COVID research, PPIE members reviewed surveys before data collection to provide feedback on usability and cognitive load. Based on their input, we introduced improvements such as a save-and-resume function, clearer navigation, progress bars, and simplified question formats. These changes substantially enhanced accessibility and user experience, resulting in a more patient-friendly design that supports meaningful engagement. Given the unpredictable and often debilitating nature of Long COVID, patient safety and infection control were central considerations throughout the study to enhance inclusivity and accessibility. PPIE input was crucial in identifying risks related to post-exertional malaise (PEM) and post-exertional symptom exacerbation (PESE), with representatives conducting remote site visits and patient walk-throughs. This collaboration informed protective measures that were tailored and implemented to account for participants’ needs, including an extensive screening protocol, co-development of symptom tracking tools, adverse event escalation pathways, and strategies to reduce participant burden. Efforts were made not only to minimise psychological distress, by addressing triggers such as medical gaslighting and past trauma, but also to protect participants’ physical health, reflecting a core commitment to patient-centred care. Preventing COVID-19 reinfection was considered particularly critical for people living with Long Covid, for whom additional infections could exacerbate symptoms and prolong recovery. Recognizing this, the study team implemented a multi-layered infection control strategy, informed directly by patient concerns, that included regular testing for staff and participants, mandatory FFP2 masks for research personnel, and enhanced ventilation with HEPA filtration in all patient-facing rooms. Airflow was continuously monitored to maintain 6–12 air changes per hour, ensuring compliance with best-practice guidelines [24]. These measures allowed participants to engage safely in the study without compromising their health, illustrating the team’s ethical commitment to listening to and accommodating patient needs, a standard that should be considered non-negotiable in Long COVID research and modern health research more broadly. Safety protocols were treated as a living process, with ongoing review and refinement based on PPIE feedback. This iterative approach not only upheld participant well-being and scientific integrity but also provides a blueprint for scaling up to larger trials involving more sites and participants with greater illness severity. Representing the community, not just the individual A key insight from this case study is the importance of ensuring that PPIE contributors are not solely representing their own experiences but are also connected to broader patient communities. In this trial, contributors with access to large peer networks were able to bring forward a wider range of perspectives, helping to ensure that the research was grounded in collective rather than individual lived experience. This was seen as particularly important for reducing the risk that feedback would be overly individualised or that the views of the most unwell participants, who may be less able to participate directly, would be underrepresented. However, the authors also acknowledge that reliance on contributors with large peer networks could introduce bias, as these networks may not be fully representative of all patient groups. This highlights the need for inclusive PPIE design that actively seeks diverse forms of engagement alongside socially well-connected contributors. This distinction is crucial in the context of a complex and heterogeneous condition such as Long COVID [25], where symptoms, trajectories, and care needs can vary widely across individuals. By drawing on insights from broader networks such as online support groups, community organisations, and patient advocacy forums, PPIE contributors acted as channels for collective voices, highlighting shared challenges and unmet needs that might not have surfaced through individual testimony alone. This approach not only strengthened the relevance and inclusivity of the research but also helped identify emerging trends and concerns within the community in real time. Moreover, community-connected contributors were better positioned to challenge assumptions, refine research priorities, and validate whether the study design reflected the real-world experiences of diverse patient populations. Their input ensured that the trial was not shaped solely by clinical or academic perspectives but was co-produced with those who carry the burden of illness. This model of representation underscores the value of cultivating PPIE contributors who are embedded in and accountable to, wider patient communities—an essential component for achieving meaningful, equitable, and impactful involvement in health research. Bespoke PPIE enablement: a flexible, individualised approach Importantly, the team recognise that traditional PPIE structures often favour individuals with milder symptoms, as they are more likely to have the capacity to participate in PPIE activities. This inadvertently contributes to the exclusion of those who are more severely affected, precisely the individuals whose insights are critical to shaping truly inclusive and accessible research. By embedding flexibility and accessibility into every stage of the process, the team sought to ensure that PPIE involvement reflected the full spectrum of experiences within the Long COVID community. Recognising that PPIE is not a one-size-fits-all process, the research team adopted a bespoke and flexible approach to enable meaningful contributions from a diverse range of individuals. From the outset, initial meetings were held to understand each PPIE contributor's preferences, capacities, and communication styles. This allowed the team to tailor engagement methods, such as offering feedback via voice notes, written responses, or asynchronous formats, to suit individual needs and fluctuating health. For example, one PPIE member completed a virtual walkthrough via video call with the study chief investigator to review the access and suitability of all data collection and treatment spaces at each study site. These approaches provided the PPIE member with a better understanding of the environments without having to expend additional energy attending the sites. Based on the feedback, adjustments were made to improve patient safety and confidence. These included: (1) lowering the light intensity of rooms to suit patient needs, (2)providing an entrance to the research labs that were less busy and closer to car parking (within 10 m of lift and 250 m to the lab thereafter), and (3) increasing access to disposable cups and water. Adjustments more specific to the ERASE-LC trial included: (1) increasing the space between treatment beds, (2) adjusting the proximity and positioning of research nurses during treatment administration, and (3) relocating and improving the position of ventilation systems equipped with HEPA filters to optimise air quality standards. Throughout the ERASE-LC study, monthly trial meetings were held between research staff and all PPIE members to discuss ongoing study progress, highlight areas of good practice, and facilitate discussion about challengesand potential adjustments. Beyond this, PPIE representatives also attended monthly trial management meetings, and had protected time within the agenda to discuss PPIE queries/activity. In addition, the team acknowledged the necessity of providing appropriate remuneration for PPIE contributors’ time and expertise throughout the trial and these costs were incorporated into the funding application at the planning stage. A reflective account of their experience as a PPIE representative in ERASE-LC Although we did not use a formal evaluation tool to assess PPIE impact, the research design, data collection, and dissemination for the research group's work are continuously reviewed with the PPIE team through regular online meetings. Feedback is gathered in ways that are inclusive and accessible, forming the basis of an evaluation approach rooted in patient voices rather than rigid models. The effectiveness of the PPIE within the research groups work is evidenced by the trust and reputation we hold within the Long COVID community, allowing us to address limitations of quantitative tools. For example, PPIE members not only identify areas for improvement but also actively collaborate on solutions, ensuring accountability and driving meaningful change beyond what a single score could capture. Below we present verbatim reflections from three of the PPIE members at the centre of ERASE-LC. Throughout the entire project I have been treated as a peer, a respected colleague and as someone who has a unique and valuable perspective within the team. I have been regularly and consistently consulted with and listened to, and a culture of openness has allowed me to challenge ideas and procedures to ensure they fully reflect and respect patient needs. Whilst my health may be poor the team have found ways to enable me to participate at every point. I have attended Teams meetings lying down with my camera off, given brutally honest feedback via voice notes as I don’t have the energy to type with all the usual social conventions and been given long deadlines to take into account health challenges. The project has been driven by patient need and experience. Patients are the experts in their conditions and everyone in the team has respected and used this to create a study which holds the lived experience at the very heart of it. My involvement with ERASE has felt empowering and validating in a patient journey which is all too frequently the opposite of this. Contribution is invited, heard and acted upon with input leading to meaningful, noticeable change. Being viewed and treated as an expert by experience has enabled participation in a meaningful way, ensuring that patient voice shapes and guides the whole process of research. My involvement in the ERASE project as a lived experience partner has felt thoughtful and genuinely considered. What has stood out for me is that lived experience is valued not just for insight, but also as expertise and as empirical data in its own right. Lived experience partners are put at the heart of the work, with real space to reflect, question assumptions, and influence the direction of the project in meaningful ways. Sustained relationships have developed over time between the PPIE group and the researchers, creating a sense of mutual respect and shared purpose. Overall, the involvement has felt respectful and reciprocal, with clear care taken around relationships, pace, and inclusion, rather than involvement being rushed for its own sake. Challenges in the development and implementation of PPIE practices within ERASE-LC One concern of the PPIE group during ERASE-LC related to the role of exercise for people with Long COVID. For example, incorporating cardiopulmonary exercise testing (CPET) was a major concern for PPIE members due to the risk posed by PEM, a symptom that affects between 50 and 80% of people with Long COVID and can result in a severe clinical outcome [26]. Although this concern arose during the ERASE-LC trial, exercise for those living with Long COVID remains a contentious topic among researchers, healthcare professionals, and patients [27, 28]. In response, the research team worked collaboratively with PPIE members to design and implement an extensive and objective screening process to determine and mitigate against the risk of PEM ahead of trial participation. This proactive approach was highly successful, and no adverse reactions or PEM episodes occurred following CPET. This outcome highlights the critical role of PPIE in shaping safe and patient-centred research practices. Another challenge during the ERASE-LC trial was managing patients' requests alongside what was operationally feasible for the research team. For example, some PPIE members advocated for mandatory face masking and daily SARS-CoV-2 testing for all hospital staff during infusions. However, these measures could not be enforced because they were outside the scope of local trust policy. In response, the team adopted a pragmatic approach: FFP2 masks were worn by research staff at all sites, with signage encouraging their use by anyone entering research or treatment areas, and lateral flow tests were provided for all staff, patients, and their families to enable testing. The benefits of ensuring patient safety via masking was promoted within site initiation visits and included in training logs. This approach reflects the team’s commitment to patient safety and working with PPIE to implement meaningful changes wherever possible and despite existing external constraints. Six recommendations for effective PPIE Here we provide six recommendations for embedding PPIE successfully into health research (Fig. 2). These recommendations were co-developed by the author team and the wider PPIE network through an iterative and collaborative process, drawing on collective expertise and critical engagement with established PPIE frameworks, standards, and scoping of the related literature. Rather than proposing an alternative model, the recommendations are intended to align with, operationalise, and extend existing guidance by translating high-level principles into actionable considerations across the research lifecycle. Recommendations were refined and agreed through structured discussion and synthesis, and are intended to inform the design of individual studies and research programmes, as well as PPIE training and policy initiatives, thereby supporting more consistent, transparent and context-sensitive implementation of PPIE in practice. Six recommendations on how PPIE can be embedded successfully into health research Integrate PPIE early and throughout the research lifecyle Involve patients and the public from study conception through design, delivery, interpretation, and dissemination, ensuring that lived experience meaningfully shapes research priorities and outcomes rather than being confined to consultation stages [29]. Embed contributors within governance and decision-making structures (e.g., steering or advisory groups), and recognise substantive contributions through appropriate acknowledgement or co-authorship where criteria are met, consistent with best practice in Long COVID research [29, 30]. Prioritise inclusive, flexible and accessible practices Adopt flexible formats and tiered models of involvement that offer multiple modes and intensities of participation (e.g., voice notes, asynchronous feedback, written comments, short virtual meetings) to accommodate symptom fluctuation, fatigue, and PESE common in Long COVID [29]. Adjust meeting length, timelines, and communication formats to individual needs, and use clear, accessible language to reduce cognitive and physical burden on contributors [29]. Apply trauma-informed, empathetic, and culturally sensitive approaches to engagement, recognising the contested, uncertain and often distressing nature of Long COVID experiences [31]. Foster community-connected and collective representation Engage contributors who are connected to wider patient, advocacy, or community networks to ensure that PPIE reflects collective perspectives and shared priorities rather than isolated individual experiences [29]. Draw on insights from established Long COVID advocacy groups and online communities to surface common needs, safety concerns, and areas of contention within the evidence base [29]. Support researcher readiness and reflexivity Provide training and support for researchers and trainees on inclusive engagement, health equity, and working with lived experience, recognising that effective PPIE requires specific skills and institutional support [32]. Actively address hierarchical dynamics and power imbalances by encouraging reflexivity, openness to challenge, and transparency in researcher-contributor relationships, particularly in areas of scientific or clinical controversy [31]. Enable robust and meaningful evaluation of PPIE Evaluate PPIE using a combination of quantitative and qualitative approaches (e.g., reflective discussions, interviews, focus groups and structured feedback tools) with contributors involved in interpreting findings where possible [29]. Avoid over-reliance on summary scores or checklist compliance alone; instead, use evaluation outputs to stimulate dialogue, identify areas for improvement and demonstrate the impact of PPIE on research decisions [31]. Institutionalise meaningful PPIE Ensure PPIE is adequately resourced through dedicated funding, time and coordination (e.g., named PPIE leads), and recognise experiential expertise as integral to high-quality Long COVID research [29]. Advocate for transparent reporting of PPIE methods and impact within publications, including dedicated PPIE sections, to support shared learning and move beyond tokenistic reporting driven solely by journal requirements [31, 32]. Conclusion This paper and case study demonstrate how meaningful PPIE can be achieved through inclusive, accessible, and co-produced approaches across the research lifecycle. These experiences highlight that thoughtful, methodologically informed involvement can enhance research relevance and rigour, moving well beyond tokenistic consultation. We also highlight strategies to minimise reinfection risk in Long COVID research, a rarely addressed aspect in the existing literature. Key lessons include the value of engaging contributors as equal partners in shaping research questions, refining methods and ethical safeguards, and supporting interpretation of findings. Acknowledgements We would like to express our sincere gratitude to the Patient and Public Involvement and Engagement (PPIE) representatives who contributed their time, insight and lived experience to this work. Their perspectives were invaluable in shaping the research questions, study design and interpretation of findings, ensuring that this research remained grounded in issues that matter to patients and the wider public. This work would not have been possible without their meaningful involvement, and we acknowledge their contributions as an essential part of the research process. Author contributions M.F., L.S., and R.O. conceptualised the manuscript. R.O. drafted the main manuscript text with support for L.S, while M.F. prepared the figures. All authors contributed to the clinical trial described in the manuscript and were responsible for the integration and learnings from PPIE. The LC PPIE Research Group provided reflections and quotations. All authors reviewed and approved the final version of the manuscript. Funding This study was supported by an unrestricted investigator-sponsored research grant from Gilead Sciences (Protocol #CO-UK-540-6640). Data availability No datasets were generated or analysed during the current study. Declarations Human ethics N/A. Consent to participate Consent was obtained from all individuals whose quotes are included. The LC PPIE Research group are authors on the paper and approved the submission. Competing interests The authors declare no competing interests. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Contributor Information M. A. Faghy, Email: m.faghy@derby.ac.uk R. Owen, Email: R.Owen@Derby.ac.uk References Associated Data Data Availability Statement No datasets were generated or analysed during the current study.